|
CHMP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.706630E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.728000E-02 |
| Normal-vs-Stage2 |
3.931800E-01 |
| Normal-vs-Stage3 |
5.274400E-01 |
| Normal-vs-Stage4 |
7.490000E-01 |
| Stage1-vs-Stage2 |
2.863900E-02 |
| Stage1-vs-Stage3 |
2.991600E-01 |
| Stage1-vs-Stage4 |
3.104200E-01 |
| Stage2-vs-Stage3 |
2.067400E-01 |
| Stage2-vs-Stage4 |
3.251800E-01 |
| Stage3-vs-Stage4 |
8.472000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.194800E-01 |
| Normal-vs-AfricanAmerican |
6.870000E-02 |
| Normal-vs-Asian |
4.380000E-01 |
| Caucasian-vs-AfricanAmerican |
1.561420E-01 |
| Caucasian-vs-Asian |
9.962600E-01 |
| AfricanAmerican-vs-Asian |
2.196400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.701600E-01 |
| Normal-vs-Female |
5.507800E-02 |
| Male-vs-Female |
3.368000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.512000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.403200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.699800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.163600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.233800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.056500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.917800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.581800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.649000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.477000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.217600E-01 |
| Classical-VS-Follicular |
1.481730E-02 |
| Classical-VS-Other |
5.398200E-01 |
| Classical-VS-Normal |
4.310300E-02 |
| Tall-VS-Follicular |
4.695900E-02 |
| Tall-VS-Other |
3.350800E-01 |
| Tall-VS-Normal |
4.819900E-02 |
| Follicular-VS-Other |
8.511800E-01 |
| Follicular-VS-Normal |
5.280600E-01 |
| Other-VS-Normal |
9.779000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.467600E-01 |
| Normal-vs-N1 |
9.713000E-01 |
| N0-vs-N1 |
7.358200E-01 |
|
|
